Digital Diagnostics Data, Analytics & Interoperability: Features, Pricing & Alternatives

FDA-cleared autonomous AI that diagnoses diabetic retinopathy at the point of care.

Data, Analytics & Interoperability Cloud-Based / On-Premise Point-Of-Care Imaging Device

Digital Diagnostics develops LumineticsCore, an autonomous AI platform for point-of-care detection of diabetic retinopathy and macular edema from retinal images.

  • Founded: 2010
  • HQ: Coralville, Iowa, USA
  • Best for: Primary care and point-of-care organizations seeking to close the diabetic eye exam care gap with autonomous AI diagnostics.
  • Our take

    Digital Diagnostics is best suited for Primary care and point-of-care organizations seeking to close the diabetic eye exam care gap with autonomous AI diagnostics.. FDA-cleared autonomous AI diagnostic platform that diagnoses without physician input.

    Main limitation: focused on a single diagnostic area (diabetic retinopathy) rather than broad ehr functionality. Scored 3.1/5 across the EHRAtlas scorecard.

    Digital Diagnostics Overview

    Digital Diagnostics is a healthcare AI company focused on autonomous diagnostic platforms, best known for LumineticsCore® (formerly IDx-DR), a system that detects diabetic retinopathy and macular edema from retinal fundus images. The company describes itself as the first to receive FDA clearance to diagnose with an AI diagnostic platform without physician input, positioning its technology as a point-of-care solution that brings specialty-level eye screening into primary care and endocrinology settings.

    The distinctive mechanism is a 30-second algorithm that analyzes submitted retinal images and returns a diagnostic result at the point of care, enabling clinicians to either expedite referrals to eye care when disease is detected or schedule retesting in 12 months when it is not. The company emphasizes closing the diabetes eye exam care gap, improving HEDIS, MIPS, and Stars ratings, and reimbursement via CPT code 92229. Its stated mission is to transform the affordability, accessibility, and quality of healthcare worldwide through automation of medical diagnosis.

    Digital Diagnostics traces its origins to founder Dr. Michael Abramoff, who envisioned using computers to help diagnose patients earlier. The company is actively researching additional applications of fundus imaging for AI diagnostics, including glaucoma, cardiovascular indications, age-related macular degeneration, and neurodegenerative indications.

    Named customers reported on the vendor site include Tarzana Treatment Centers, Johns Creek Primary Care, Cahaba Medical Care, Zufall Health, University Medical Center, OSF HealthCare.

    Reported scale: First company to receive FDA clearance to diagnose with an AI diagnostic platform without physician input; Most researched autonomous AI diagnostic solution for diabetic eye disease; 85% of patients with diabetes do not get an annual eye exam.

    Latest Digital Diagnostics News

    Digital Diagnostics Evaluation

    Scored against the same 7 dimensions used in the EHRAtlas Scorecard. 0 = not enough public information to score. These are analyst estimates, not endorsements — verify during a demo. Buyers should validate capabilities, pricing, implementation requirements, and fit during vendor evaluation.

    Product Maturity 4/5

    Age, customer base, feature depth.

    LumineticsCore has been FDA-cleared since 2018 and is deployed in health systems and community clinics, with a dedicated CPT code and published clinical evidence. The product line remains narrow, centered on retinal diagnostics rather than a broad platform.

    Target Market 3/5

    Solo/small, mid, enterprise, or niche.

    Primary care, endocrinology, and point-of-care clinics are the core buyers, spanning independent practices to large health systems. The offering is specialized rather than a general EHR or RCM platform, so it serves a niche diagnostic use case.

    Key Differentiators 5/5

    What sets it apart from alternatives.

    FDA-cleared autonomous AI diagnostic that makes a diagnosis without physician interpretation, with 30-second results, a dedicated CPT code (92229), and quality-measure recognition across HEDIS, MIPS, and Stars.

    Integrations 3/5

    Systems it connects to out of the box.

    Epic integration is documented through customer deployments, and the company references EHR integration of its FDA-cleared system. A complete list of supported EHRs, modalities, and interfaces is not published.

    Compliance & Certifications 4/5

    HIPAA, SOC 2, ONC, FDA, other.

    FDA clearance for LumineticsCore is the standout credential, and the company emphasizes ethical AI governance. HIPAA and SOC 2 status are not publicly documented, and the product is not ONC-certified because it is not an EHR.

    Support Model 2/5

    In-house vs outsourced, SLAs, channels.

    Training courses are offered for LumineticsCore, but public materials do not describe support tiers, SLAs, or whether support is delivered in-house or through partners.

    Pricing Model 1/5

    How it charges and what the entry point is.

    No list pricing or subscription structure is published. The company points to reimbursement via CPT code 92229 as the economic model, with device and service pricing handled through sales.

    Digital Diagnostics Pricing

    Practice SizeMonthly (per provider)ImplementationNotes
    Solo Contact vendor Contact vendor Reimbursable via CPT code 92229; no list pricing published.
    Small Contact vendor Contact vendor Reimbursable via CPT code 92229; no list pricing published.
    Mid Contact vendor Contact vendor Reimbursable via CPT code 92229; no list pricing published.
    Enterprise Contact vendor Contact vendor Reimbursable via CPT code 92229; no list pricing published.

    Pricing is indicative. Always request a formal quote and ask about module, interface, and annual maintenance fees.

    Key Features

    Autonomous diabetic retinopathy diagnosis

    LumineticsCore diagnoses diabetic retinopathy, including macular edema, without physician input at the point of care.

    30-second results

    The system can provide a diagnosis within 30 seconds of image submission.

    Care gap closure

    Designed to close the diabetes eye exam care gap and improve HEDIS, MIPS, and Stars ratings.

    Reimbursement support

    LumineticsCore is reimbursable using CPT code 92229.

    SphereDx results platform

    A securely hosted diagnostic results platform built for Digital Diagnostics systems.

    Product training

    Training courses are available for LumineticsCore and other Digital Diagnostics tools.

    Fit

    Specialties Served

    Integrations & Compliance

    Capabilities

    autonomous-ai diabetic-retinopathy-screening point-of-care-diagnostics care-gap-closure quality-measure-improvement

    Systems It Connects To

    Compliance

    ItemStatusNote
    ONC Certified Health IT No Not listed in the ONC CHPL active database.
    FDA cleared Yes LumineticsCore received FDA clearance in April 2018 as an autonomous AI diagnostic platform.
    HIPAA Not published Not explicitly stated in the supplied text.
    SOC 2 Not published Not stated in the supplied text.

    Digital Diagnostics Pros & Cons

    Pros

    • FDA-cleared autonomous AI diagnostic platform that diagnoses without physician input
    • Provides results within 30 seconds at the point of care
    • Reimbursable via CPT code 92229
    • Helps close HEDIS/MIPS/Stars care gaps for diabetic eye exams
    • Backed by published case studies and clinical evidence

    Cons

    • Focused on a single diagnostic area (diabetic retinopathy) rather than broad EHR functionality
    • Pricing is not publicly disclosed
    • Limited detail on support model and SLAs
    • Integration details beyond Epic are not clearly documented

    Explore EHR Software Ecosystem: Integrations, Partners & Add-Ons Compare Digital Diagnostics with other Endocrinology and Ophthalmology EHR vendors or browse the full EHR & Healthcare Technology Solutions Index.

    Are you Digital Diagnostics? Claim your vendor profile, add product details, and reach practices researching EHRs. Claim Profile/Get Listed

    Spotted an error? We publish this data as-is from CMS sources. If a practice or vendor listing is wrong, email support@ehratlas.com and we'll review it.

    About This Data & Methodology

    Source: This profile is assembled from the vendor's public website (features, capabilities, customer stories, media, and product updates) and EHRAtlas analyst evaluation. Compliance claims, pricing, and integration details should be verified directly with the vendor before making a purchase decision.

    Methodology: Where available, we extract structured facts (customers, outcomes, integrations, security certifications) directly from the vendor's own published pages. Claims are linked to their source. Scores reflect analyst judgment based on available public evidence and are not endorsements.

    Updates: Vendors are re-scanned periodically. Profile last reviewed on the date shown in the hero.

    Corrections: If you spot an error or a change in the vendor's product, capabilities, or pricing, email us and we'll review it.

    Spotted an error or need to submit a correction? Email support@ehratlas.com.

    ✨ EHR Matchmaker Visit Digital Diagnostics ↗ For vendors: Claim profile →